首页> 外文期刊>PLoS One >Trends in opioid prescribing practices in South Korea, 2009–2019: Are we safe from an opioid epidemic?
【24h】

Trends in opioid prescribing practices in South Korea, 2009–2019: Are we safe from an opioid epidemic?

机译:2009 - 2019年,韩国阿片类药物处方实践的趋势:我们是否从阿片类药物流行中安全?

获取原文
获取外文期刊封面目录资料

摘要

Opioid prescribing data can guide regulation policy by informing trends and types of opioids prescribed and geographic variations. In South Korea, the nationwide data on prescribing opioids remain unclear. We aimed to evaluate an 11-year trend of opioid prescription in South Korea, both nationally and by administrative districts. A population-based cross-sectional analysis of opioid prescriptions dispensed nationwide in outpatient departments between January 1, 2009, and December 31, 2019, was conducted for this study. Data were obtained from the Health Insurance Review & Assessment Service. The types of opioids prescribed were categorized into total, strong, and extended-release and long-acting formulation. Trends in the prescription rate per 1000 persons were examined over time nationally and across administrative districts. There are significant increasing trends for total, strong, and extended-release and long-acting opioid prescriptions (rate per 1000 persons in 2009 and 2019: total opioids, 347.5 and 531.3; strong opioids, 0.6 and 15.2; extended-release and long-acting opioids, 6.8 and 82.0). The pattern of dispensing opioids increased from 2009 to 2013 and slowed down from 2013 to 2019. The rate of opioid prescriptions issued between administrative districts nearly doubled for all types of opioids. Prescription opioid dispensing increased substantially over the study period. The increase in the prescription of total opioids was largely attributed to an increase in the prescription of weak opioids. However, the increase in prescriptions of extended-release and long-acting opioids could be a future concern. These data may inform government organizations to create regulations and interventions for prescribing opioids.
机译:Apioid规定数据可以通过通知规定和地理变异的趋势和类型来指导监管政策。在韩国,全国范围的特定阿片类药物的数据仍然不清楚。我们旨在评估韩国的韩国阿片类药物的11年趋势,全国范围内和行政区。为本研究进行了一项基于人群的基于阿片类药物处方的横截面分析,在2009年1月1日至2019年12月31日,为2019年12月31日。数据是从健康保险审查和评估服务获得的。规定的阿片类药物的类型分为总,强,延长,延长释放和长效配方。每1000人处方率的处方率的趋势在全国各地和行政区审查。总体,强大和延长释放和长效的阿片类药物处方有显着提高趋势(2009年和2019年的每1000人):总阿片类药物,347.5和531.3;强壮的阿片类药物,0.6和15.2;延长释放和长期作用阿片类药物,6.8和82.0)。分配阿片类药物的模式从2009年到2013年增加,从2013年到2019年放缓。行政区之间发出的阿片类药物处方的率几乎加倍,适用于所有类型的阿片类药物。处方阿片类药物分配在研究期间大幅增加。总阿片类药物的处方增加归因于弱阿片类药物处方的增加。然而,延长释放和长效的阿片类药物处方的增加可能是未来的关注。这些数据可以为政府组织通知政府组织为处方阿片类药物制定法规和干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号